author-photo

Luisa Fernandez

94

Papers

240

Citations

Citation Trend

Filter By

Papers (69) Sort By

Journal Conference Others

Childhood Obesity and Risk of SARS-CoV-2 Infection

2021 Social Science Research Network
Show All
- Source
- Cite
- Save
Citations (0)
Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 2899: Single-cell analyses reveal increasing intratumoral heterogeneity as an essential component of treatment resistance in small cell lung cancer

2019 Tumor Biology
Show All
- Source
- Cite
- Save
Citations (0)
Energy Storage. Our take on business model and regulation

2019
Show All
- Source
- Cite
- Save
Citations (0)
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer

2019 Science Translational Medicine
Show All
- Source
- Cite
- Save
Citations (42)
Abstract 2215: SLFN11 and EZH2 protein expression and localization in circulating tumor cells to predict response or resistance to DNA damaging therapies in small cell lung cancer

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
SLFN11 expression (exp) in castration-resistant prostate cancer (CRPC) patients (pts) to predict response to platinum-based chemotherapy (PLT).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1348: Characterization of SLFN11 protein expression in circulating tumor cells (CTCs) of patients with metastatic castration resistant prostate cancer (mCRPC) prior to platinum based chemotherapy

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Estudio multicéntrico español: niños con hiperamoniemia no asociada a errores innatos del metabolismo

2017 Nutricion Hospitalaria
Show All
- Source
- Cite
- Save
Citations (0)
Glucocorticoid receptor (GR) expression in circulating tumor cells (CTCs) to prognosticate overall survival (OS) for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with androgen receptor signaling inhibitors (ARSi).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)